$316 Million is the total value of Prosight Management, LP's 41 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 48.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PCRX | Sell | PACIRA BIOSCIENCES INC | $37,134,366 | -47.2% | 1,210,377 | -31.0% | 11.77% | +11.7% |
| HUM | Sell | HUMANA INC | $31,623,800 | -35.8% | 65,000 | -41.0% | 10.02% | +35.7% |
| GLPG | Sell | GALAPAGOS NVspon adr | $25,228,652 | -25.7% | 730,207 | -12.6% | 8.00% | +57.2% |
| MGTX | Sell | MEIRAGTX HLDGS PLC | $20,026,928 | -45.5% | 4,078,804 | -25.4% | 6.35% | +15.2% |
| KURA | Sell | KURA ONCOLOGY INC | $17,623,999 | -38.0% | 1,932,456 | -28.1% | 5.58% | +31.1% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $17,049,596 | -51.6% | 2,408,135 | -51.8% | 5.40% | +2.4% |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $15,607,802 | -63.6% | 2,579,802 | -53.3% | 4.95% | -23.0% |
| MDT | Buy | MEDTRONIC PLC | $11,754,000 | +11.2% | 150,000 | +25.0% | 3.72% | +135.2% |
| ABCL | Sell | ABCELLERA BIOLOGICS INC | $11,251,600 | -65.8% | 2,446,000 | -52.0% | 3.57% | -27.8% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $11,170,853 | -68.0% | 353,508 | -73.8% | 3.54% | -32.4% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $9,000,000 | -71.9% | 80,000 | -76.5% | 2.85% | -40.6% |
| NARI | Sell | INARI MED INC | $8,502,000 | -38.4% | 130,000 | -45.2% | 2.69% | +30.3% |
| INSP | New | INSPIRE MED SYS INC | $7,937,600 | – | 40,000 | +100.0% | 2.52% | – |
| OPCH | Sell | OPTION CARE HEALTH INC | $7,117,000 | -53.5% | 220,000 | -53.3% | 2.26% | -1.8% |
| Sell | QUIDELORTHO CORP | $6,208,400 | -66.1% | 85,000 | -61.5% | 1.97% | -28.3% | |
| PRTA | Sell | PROTHENA CORP PLC | $6,089,247 | -62.8% | 126,202 | -47.4% | 1.93% | -21.4% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $5,927,591 | -63.4% | 3,446,274 | -13.8% | 1.88% | -22.6% |
| DXCM | New | DEXCOM INC | $5,823,879 | – | 62,421 | +100.0% | 1.85% | – |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $5,677,251 | -75.1% | 4,770,799 | -48.7% | 1.80% | -47.3% |
| CNC | Sell | CENTENE CORP DEL | $5,510,400 | -79.1% | 80,000 | -79.6% | 1.75% | -55.9% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $5,141,100 | – | 40,890 | +100.0% | 1.63% | – |
| ADCT | Sell | ADC THERAPEUTICS SA | $4,845,631 | -79.8% | 5,402,041 | -51.6% | 1.54% | -57.3% |
| TDOC | Buy | TELADOC HEALTH INC | $4,647,500 | +19.3% | 250,000 | +62.5% | 1.47% | +152.7% |
| MASI | New | MASIMO CORP | $3,507,200 | – | 40,000 | +100.0% | 1.11% | – |
| GRPH | Sell | GRAPHITE BIO INC | $3,317,808 | -62.5% | 1,337,826 | -60.7% | 1.05% | -20.6% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $3,299,100 | -56.1% | 35,000 | -51.4% | 1.05% | -7.1% |
| PEN | New | PENUMBRA INC | $3,265,785 | – | 13,500 | +100.0% | 1.04% | – |
| STTK | Sell | SHATTUCK LABS INC | $3,226,960 | -75.5% | 2,123,000 | -49.7% | 1.02% | -48.1% |
| DSGN | New | DESIGN THERAPEUTICS INC | $2,840,838 | – | 1,203,745 | +100.0% | 0.90% | – |
| BBSI | New | BARRETT BUSINESS SVCS INC | $1,929,963 | – | 21,387 | +100.0% | 0.61% | – |
| CMPX | Sell | COMPASS THERAPEUTICS INC | $1,842,259 | -73.3% | 935,157 | -56.9% | 0.58% | -43.5% |
| ALKS | Sell | ALKERMES PLC | $1,820,650 | -80.3% | 65,000 | -78.0% | 0.58% | -58.3% |
| LBPH | Sell | LONGBOARD PHARMACEUTICALS IN | $1,785,616 | -83.4% | 321,154 | -78.1% | 0.57% | -65.0% |
| NUVB | Sell | NUVATION BIO INC | $1,407,000 | -64.5% | 1,050,000 | -52.3% | 0.45% | -24.8% |
| AGL | Sell | AGILON HEALTH INC | $1,404,390 | -59.5% | 79,076 | -60.5% | 0.44% | -14.4% |
| BMEA | New | BIOMEA FUSION INC | $1,304,682 | – | 94,817 | +100.0% | 0.41% | – |
| CHE | New | CHEMED CORP NEW | $1,299,250 | – | 2,500 | +100.0% | 0.41% | – |
| EOLS | New | EVOLUS INC | $1,160,615 | – | 126,982 | +100.0% | 0.37% | – |
| New | ZYMEWORKS INC | $674,608 | – | 106,405 | +100.0% | 0.21% | – | |
| Sell | ERASCA INC | $521,479 | -93.9% | 264,710 | -91.5% | 0.16% | -87.2% | |
| AZYO | Sell | ELUTIA INC | $36,599 | -97.6% | 25,594 | -96.1% | 0.01% | -94.8% |
| Exit | THE ONCOLOGY INSTITUTE INC | $0 | – | -910,604 | -100.0% | -0.08% | – | |
| Exit | ALDEYRA THERAPEUTICS INCcall | $0 | – | -751,200 | -100.0% | -0.10% | – | |
| MODV | Exit | MODIVCARE INC | $0 | – | -32,046 | -100.0% | -0.22% | – |
| Exit | TRINET GROUP INCput | $0 | – | -1,621,893 | -100.0% | -0.25% | – | |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -299,022 | -100.0% | -0.38% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -628,600 | -100.0% | -1.17% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -30,000 | -100.0% | -2.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
| ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
| MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
| KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
| ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
| IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
| CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
| CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
| PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
| ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
| Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
| Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
| Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
| Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
| OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
| CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
| Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-02 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-09-01 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.